Skip to main content
Addgene

pcDNA3-HA-Cul7
(Plasmid #20696)

Full plasmid sequence is not available for this item.

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 20696 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pcDNA3
  • Backbone manufacturer
    Invitrogen
  • Backbone size w/o insert (bp) 4620
  • Vector type
    Mammalian Expression
  • Selectable markers
    G418

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    cullin 7
  • Alt name
    KIAA0076
  • Alt name
    CUL7
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    5124
  • GenBank ID
    Q14999
  • Entrez Gene
    CUL7 (a.k.a. 3M1, CUL-7, KIAA0076, dJ20C7.5)
  • Tag / Fusion Protein
    • HA (N terminal on insert)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site BamHI (not destroyed)
  • 3′ cloning site NotI (not destroyed)
  • 5′ sequencing primer T7
  • 3′ sequencing primer SP6
  • (Common Sequencing Primers)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pcDNA3-HA-Cul7 was a gift from Yue Xiong (Addgene plasmid # 20696 ; http://n2t.net/addgene:20696 ; RRID:Addgene_20696)
  • For your References section:

    Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function. Andrews P, He YJ, Xiong Y. Oncogene. 2006 Aug 3. 25(33):4534-48. 10.1038/sj.onc.1209490 PubMed 16547496